Marek Sanak
Impact in
- Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization
- Pharmacology top 0.5%
- Drug-Induced Adverse Reactions
- Inflammatory mediators and NSAID effects
Papers in
- Physiology 86
- Asthma and respiratory diseases 81
-
- Allergic Rhinitis and Sensitization 13
- Co-authors
- A SzczeklikAndrzej SzczeklikLucyna MastalerzBogdan JakiełaWojciech SzczeklikJacek MusiałHanna PluteckaAnna Gielicz
- Journals
- Allergy (14 papers)Journal of Allergy and Clinical Immunology (11 papers)Clinical & Experimental Allergy (9 papers)Clinical & Experimental Immunology (5 papers)Thrombosis Research (4 papers)
- Partner nations
- PolandUnited StatesUnited Kingdom
In The Last Decade
Marek Sanak
262 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 156
- Immunology and Allergy 563
- Pharmacology 1.4k
- Physiology 2.1k
- Rheumatology 909
- Pulmonary and Respiratory Medicine 1.5k
Countries citing papers authored by Marek Sanak
This map shows the geographic impact of Marek Sanak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Sanak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Sanak more than expected).
Fields of papers citing papers by Marek Sanak
This network shows the impact of papers produced by Marek Sanak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Sanak. The network helps show where Marek Sanak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marek Sanak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 13 | |
| 8 | 2020 | 57 | |
| 9 | 2020 | 45 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 3 | |
| 12 | 2019 | 21 | |
| 13 | 2015 | 24 | |
| 14 | 2013 | 33 | |
| 15 | 2012 | 4 | |
| 16 | Assessment of the latent tuberculosis infection (LTBI) with QuantiFERON-GIT (QFT-GIT) assay in selected risk groups in Krakow | 2009 | 1 |
| 17 | Asthmatic bronchial fibroblasts demonstrate enhanced potential to differentiate into myofibroblasts in culture. | 2009 | 51 |
| 18 | [Autosomal dominant hypercholesterolemia - underrecognised diagnostic and clinical problem]. | 2009 | 2 |
| 19 | [Molecular studies in a population of children with bronchial asthma. I. Polymorphism in the promotor region of gene CD14]. | 2001 | 10 |
| 20 | 2000 | 137 |
About Marek Sanak
Marek Sanak is a scholar working on Physiology, Immunology and Allergy, Pharmacology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 270 papers that have together received 5.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (81 papers), Drug-Induced Adverse Reactions (43 papers), Inflammatory mediators and NSAID effects (23 papers), Respiratory and Cough-Related Research (23 papers), Urticaria and Related Conditions (19 papers), Vasculitis and related conditions (16 papers), Retinal Diseases and Treatments (14 papers) and Allergic Rhinitis and Sensitization (13 papers). The work is most often cited by research in Immunology and Allergy (563 citations), Pharmacology (1.4k citations), Physiology (2.1k citations), Rheumatology (909 citations) and Pulmonary and Respiratory Medicine (1.5k citations). Marek Sanak has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include A Szczeklik, Andrzej Szczeklik, Lucyna Mastalerz, Bogdan Jakieła, Wojciech Szczeklik, Jacek Musiał, Hanna Plutecka, Anna Gielicz, Jerzy Soja and Grażyna Bochenek. Their work appears in journals such as Allergy, Journal of Allergy and Clinical Immunology, Clinical & Experimental Allergy, Clinical & Experimental Immunology and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.